Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

MAZE

Maze Therapeutics Inc

May 29 • 04:00PM ET

26.46

+0.06 0.23 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: KYMR NUVL BMRN RYTM INCY KRYS VKTX AXSM MDGL NBIX

| Held by: VTI IWM VXF IBB IWN VTWO XPH SCHA VFMO IWC

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-2.54	Insider Own	37.90%	Shs Outstand	49.74M	Perf Week	2.76%
Market Cap	1.46B	Forward P/E	-	EPS next Y	-3.22	Insider Trans	-1.67%	Shs Float	34.40M	Perf Month	3.04%
Enterprise Value	1.17B	PEG	-	EPS next Q	-0.72	Inst Own	57.56%	Short Float	11.49%	Perf Quarter	-41.96%
Income	-122.54M	P/S	73.22	EPS this Y	9.83%	Inst Trans	8.26%	Short Ratio	4.56	Perf Half Y	-27.90%
Sales	20.00M	P/B	3.85	EPS next Y	-17.11%	ROA	-32.57%	Short Interest	3.95M	Perf YTD	-36.13%
Book/sh	6.87	P/C	4.16	EPS next 5Y	-6.01%	ROE	-38.67%	52W High	53.65 -50.68%	Perf Year	117.42%
Cash/sh	6.37	P/FCF	-	EPS past 3/5Y	-0.41% -	ROIC	-30.78%	52W Low	9.73 171.89%	Perf 3Y	-
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	89.19%	Volatility	4.34% 5.01%	Perf 5Y	-
Dividend TTM	-	EV/Sales	58.66	EPS Y/Y TTM	-	Oper. Margin	-670.25%	ATR (14)	1.44	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	17.88	Sales Y/Y TTM	-	Profit Margin	-612.71%	RSI (14)	47.23	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	17.88	EPS Q/Q	39.99%	SMA20	1.84%	Beta	2.27	Target Price	62.55
Payout	-	Debt/Eq	0.18	Sales Q/Q	-	SMA50	-8.00%	Rel Volume	0.78	Prev Close	26.40
Employees	141	LT Debt/Eq	0.16	Earnings	May 12 AMC	SMA200	-19.96%	Avg Volume	865.91K	Price	26.46
IPO	Jan 31, 2025	Option/Short	Yes / Yes	EPS/Sales Surpr.	21.98% 88.24%	Trades		Volume	673,708	Change	0.23%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)